AU Stocks
US Stocks
US Options
Emerging Asia
Cash Management
Margin Lending
Smart Portfolio
MoneybullP
PLX
Protalix Biother
1.18
0.04+3.51%Opening15:27 05/20 EDT
OPEN/PREV CLOSE1.145/1.140
TODAY RANGE1.130-1.180
VOL284.06K
MARKET CAP86.51M
52 WEEK RANGE1.031-2.505
AVG VOL (3M)423.55K
% TURNOVER0.39%
TURNOVER0
P/E (TTM)19.44
% RANGE4.39%
EPS(TTM)0.0607
P/E(FORWARD)5.62
P/B2.894
BVPS0.4077
DIVIDEND--
P/S1.314
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP73.90M
SHARES OUTSTANDING73.32M
NEXT EARNINGS08/05-08/09
FREE FLOAT62.63M
LOT SIZE1
EX-DIV DATE12/20/2019
News
Press Releases
Financial Reports
Profile
Benzinga·3d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press release·05/10 23:19
Protalix Biotherapeutics, Inc. Form 10-Q for the Quarterly Period Ended March 31, 2024
Investorplace·05/10 15:54
PLX Stock Earnings: Protalix BioTherapeutics Misses EPS, Misses Revenue for Q1 2024
Seeking Alpha·05/10 14:00
Novavax, Macrogenics, Biofrontera among healthcare movers
Seeking Alpha·05/10 12:30
NOTV, BFRI and CPOP among pre-market losers
Benzinga·05/10 12:07
12 Health Care Stocks Moving In Friday's Pre-Market Session
TipRanks·05/10 11:05
Options Volatility and Implied Earnings Moves Today, May 10, 2024
NASDAQ·05/10 10:55
Protalix BioTherapeutics Inc. Q1 Loss Increases, Misses Estimates
Seeking Alpha·05/10 10:54
Protalix BioTherapeutics GAAP EPS of -$0.06 misses by $0.04, revenue of $3.75M
Seeking Alpha·05/09 16:27
Protalix BioTherapeutics Q1 Earnings Preview
Seeking Alpha·03/14 10:51
Protalix BioTherapeutics GAAP EPS of $0.09 misses by $0.01, revenue of $65.49M beats by $1.54M
PR Newswire·03/14 10:50
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Benzinga·03/14 09:52
Earnings Scheduled For March 14, 2024
Same Industry
Name/Symbol
Change%
Price